Current pharmacological treatments for bronchiolitis are useless. The case for the con's.
Bronchiolitis is a recognized syndrome seen in infants following viral infections. The pattern is different in different countries related to the socio-economic conditions. A sequel that needs to be addressed is post-viral wheeze. Oxygen is the major beneficial pharmacological agent. Bronchodilators may be effective in some. There is a role for Palivizumab and Montelukast in selected infants. It is essential to define the right drug for the right patient at the right dose and the right time.
Landau
Louis I
LI
School of Paediatrics and Child Health, The University of Western Australia, Australia. llandau@cyllene.uwa.edu.au
D000998:Antiviral Agents / Q000627:therapeutic use*; D001988:Bronchiolitis / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D010102:Oxygen Inhalation Therapy / Q000379:methods*; D016896:Treatment Outcome
D000998:Antiviral Agents; D001993:Bronchodilator Agents